High‐parameter flow cytometry for clinical laboratories—Worth it or not?
The authors declare no conflicts of interest. The views presented herein are the consensus views of the authors and not those of their respective employers.
Authors
- Robert J. Durso
- Thomas C. Beadnell (ORCID: https://orcid.org/0000-0003-0287-3836)
- Nina Rolf (ORCID: https://orcid.org/0000-0002-4531-2994)
- Sagar R. Patil
- Fernando López Ortiz (ORCID: https://orcid.org/0000-0003-1786-0157)
- Veronica Nash
- Xuehai Wang (ORCID: https://orcid.org/0000-0002-8723-7339)
- Ahmad Al-Attar
- Amanda Scott
Institutions
- University of British Columbia (CA)
- University of Pittsburgh (US)
- Regeneron (United States) (US)
- Ottawa Hospital (CA)
- GlaxoSmithKline (United States) (US)
- American College of Clinical Pharmacy (US)
- Aptose Biosciences (Canada) (CA)
- BC Children's Hospital (CA)
- Ottawa Hospital Research Institute (CA)
Publication Details
- Journal
- Cytometry Part B Clinical Cytometry
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1002/cyto.b.70021
- Primary Topic
- Single-cell and spatial transcriptomics
- Type
- article
- Field-Weighted Citation Impact
- 0.00